Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

Autor: Zhang, Haijiao, Wilmot, Beth, Bottomly, Daniel, Dao, Kim-Hien T., Stevens, Emily, Eide, Christopher A., Khanna, Vishesh, Rofelty, Angela, Savage, Samantha, Reister Schultz, Anna, Long, Nicola, White, Libbey, Carlos, Amy, Henson, Rachel, Lin, Chenwei, Searles, Robert, Collins, Robert H., DeAngelo, Daniel J., Deininger, Michael W., Dunn, Tamara, Hein, Than, Luskin, Marlise R., Medeiros, Bruno C., Oh, Stephen T., Pollyea, Daniel A., Steensma, David P., Stone, Richard M., Druker, Brian J., McWeeney, Shannon K., Maxson, Julia E., Gotlib, Jason R., Tyner, Jeffrey W. ^*

Publikováno v: In Blood 12 September 2019 134(11):867-879

Combining the Allosteric ABL1 Inhibitor Asciminib (ABL001) with Ponatinib Suppresses Emergence of and Restores Efficacy Against Highly Resistant BCR-ABL1 Compound Mutants

Autor: Eide, Christopher A. ^*, Zabriskie, Matthew S. ^*, Savage, Samantha L. ^*, Antelope, Orlando ^*, Vellore, Nadeem A. ^*, Than, Hein, Reister Schultz, Anna ^*, Clair, Phillip M. ^*, Bowler, Amber D. ^*, Pomicter, Anthony D. ^*, Yan, Dongqing ^*, Senina, Anna V. ^*, Wang, Qiang ^*, Kelley, Todd W., Szankasi, Philippe ^*, Heinrich, Michael C. ^*, Tyner, Jeffrey W., Rea, Delphine, Cayuela, Jean-Michel ^*, Kim, Dong-Wook, Tognon, Cristina E. ^*, O'Hare, Thomas, Druker, Brian J., Deininger, Michael W.

Publikováno v: In Blood 13 November 2019 134 Supplement 1:188-188

Characterizing Population Heterogeneity and Signaling Changes in Chronic Myeloid Leukemia Stem and Progenitor Cells upon Combined Treatment with Imatinib and MEK Inhibitors Using Quantitative Single Cell Phospho-Imaging

Autor: Reister Schultz, Anna ^*, Jacob, Thomas ^*, Eide, Christopher A. ^*, Savage, Samantha L ^*, Mori, Motomi ^*, Tyner, Jeffrey W., Tognon, Cristina E. ^*, Vu, Tania Q. ^*, Druker, Brian J.

Publikováno v: In Blood 29 November 2018 132 Supplement 1:4248-4248

Definition of the Minimal Truncated Elements Necessary for CSF3R Leukemogenic Potential

Autor: Zhang, Haijiao ^*, Reister Schultz, Anna ^*, Luty, Samuel B ^*, Means, Sophie ^*, David, Larry ^*, Klimek, John ^*, Bottomly, Daniel ^*, Wilmot, Beth ^*, McWeeney, Shannon ^*, Su, Yulong ^*, Tyner, Jeffrey W.

Publikováno v: In Blood 2 December 2016 128(22):2735-2735

Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.

Autor: Rosenberg MW; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97215, USA., Savage SL; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97215, USA., Eide CA; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97215, USA., Reister Schultz A; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97215, USA., Cook RJ; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97215, USA., Press RD; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Department of Pathology, Oregon Health and Science University, Portland, Oregon 97215, USA., Rempfer C; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Department of Pathology, Oregon Health and Science University, Portland, Oregon 97215, USA., Eickelberg G; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Department of Pathology, Oregon Health and Science University, Portland, Oregon 97215, USA., Wilmot B; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Bioinformatics and Computational Biology, Oregon Health and Science University, Portland, Oregon 97215, USA., McWeeney SK; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Bioinformatics and Computational Biology, Oregon Health and Science University, Portland, Oregon 97215, USA., Tyner JW; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, Oregon 97215, USA., Druker BJ; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97215, USA., Tognon CE; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon 97215, USA.; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon 97215, USA.

Publikováno v: Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2022 Oct 28; Vol. 8 (6). Date of Electronic Publication: 2022 Oct 28 (Print Publication: 2022).